Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition On February 24, 2026, Kiniksa Pharmaceuticals International, plc issued a press release announcing financial r
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Kiniksa Pharmaceuticals International